Genetic biomarkers, such as APC, KRAS, NRAS, BRAF, PIK3CA, PTEN, TP53, and NDST4, reveal critical molecular pathways involved in CRC progression and provide actionable targets for precision therapies. The gene discussed is TP53; the disease is colorectal carcinoma.